Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol peanut challenge crossover study in peanut-allergic adults
2017-005060-18Phase 2Unknown
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of allopurinol in peanut allergy (2 arms), sponsored by Manchester University NHS Foundation Trust. Primary endpoint: Mean within-participant change in peanut dose required to induce objective symptoms. Status: unknown.
02
Drugs
allopurinol
03
Conditions
peanut allergy
Beyond the preview
Go deeper on 2017-005060-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005060-18.